REELD will exhibit at ASHG 2026 — October 20–24, Montréal.Meet our team at the meeting
Transparency

What we claim, what we do not, and what should be verifiable.

Scientific credibility depends on boundaries that are as visible as the positive result.

Research status

Studies on this site are labeled by output type. Methods demonstrations and research briefs should not be read as peer-reviewed clinical evidence.

Institution references

University names identify institutions and investigators whose research or scholarship informs our work. Naming an institution does not imply a formal partnership or endorsement.

Public data

REELD follows source access conditions, retains provenance, and avoids participant re-identification. Data terms remain authoritative.

Clinical boundary

REELD content supports research prioritization. It is not medical advice, diagnostic interpretation, or a substitute for accredited clinical genetics practice.

Certifications

REELD maintains multiple organizational and professional certifications. Credential names, issuing bodies, scopes, and current status are supplied during institutional diligence for direct verification.

Standard limitations

Public cohorts can underrepresent populations, tissues, ages, and disease stages.

Single-cell references vary in sample handling, depth, annotation, and donor structure.

Phenotype records can reflect ascertainment, documentation, and ontology-version bias.

Computational convergence prioritizes a mechanism for testing. It does not establish causality.